MS case studies : latest diagnostic and therapeutic approaches

Publication date: Jun 27, 2014 5:17:23 PM

Start: Jul 10, 2014 1:00:00 PM
End: Jul 10, 2014 12:00:00 AM

Location: Gilliatt Lecture Theatre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG

Date: Thursday 10th July 1pm
Speaker: Dr Jeremy Chataway, Consultant Neurologist, Queen Square MS Centre, National Hospital for Neurology & Neurosurgery

Venue: Gilliatt Lecture Theatre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG

12.30 pm buffet lunch in Foyer Seminar Room

It is an exciting time to be involved in the treatment of multiple sclerosis (MS), over the last decade there have been a plethora of new treatments and approaches: both disease modifying and symptomatic. Central is the treatment of the early relapsing-remitting phase, with new oral (eg fingolimod) and monoclonal antibody approaches (eg natalizumab, alemtuzumab). Two cases will be presented, illustrating aspects of diagnosis and therapeutics – both benefit and risk.

Contact: Tina Holmes, t.holmes@ucl.ac.uk

Page last modified on 27 jun 14 17:14